Inhibikase Therapeutics, Inc.
IKT
$2.40
$0.041.70%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.24M | 7.94M | 9.75M | 13.25M | 16.83M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 255.90K | 331.50K | 826.10K | 714.20K | 346.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 690.50K | 331.30K | 232.40K | 244.80K | 372.60K |
| Total Current Assets | 4.19M | 8.60M | 10.81M | 14.21M | 17.55M |
|
|
|||||
| Total Current Assets | 4.19M | 8.60M | 10.81M | 14.21M | 17.55M |
| Net Property, Plant & Equipment | 186.80K | 224.00K | 260.30K | 295.60K | 330.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 4.38M | 8.83M | 11.07M | 14.51M | 17.88M |
|
|
|||||
| Total Accounts Payable | 2.53M | 1.34M | 1.29M | 646.80K | 734.60K |
| Total Accrued Expenses | 2.16M | 2.03M | 2.51M | 2.26M | 1.86M |
| Short-term Debt | 71.70K | 177.30K | 280.60K | 381.80K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 145.20K | 152.20K | 151.20K | 150.10K | 149.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 4.91M | 3.70M | 4.23M | 3.44M | 2.74M |
|
|
|||||
| Total Current Liabilities | 4.91M | 3.70M | 4.23M | 3.44M | 2.74M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 71.70K | 177.30K | 280.60K | 381.80K | -- |
| Capital Leases | -- | 25.60K | 58.30K | 90.10K | 121.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4.91M | 3.73M | 4.29M | 3.53M | 2.86M |
|
|
|||||
| Common Stock & APIC | 81.76M | 81.61M | 78.33M | 77.88M | 77.74M |
| Retained Earnings | -82.29M | -76.51M | -71.55M | -66.90M | -62.72M |
| Treasury Stock & Other | 1.80K | -1.00K | -1.80K | 900.00 | -100.00 |
| Total Common Equity | -530.60K | 5.10M | 6.78M | 10.98M | 15.02M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -530.60K | 5.10M | 6.78M | 10.98M | 15.02M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -530.60K | 5.10M | 6.78M | 10.98M | 15.02M |
|
|
|||||
